SCYNEXIS, Inc. Selling, General and Administrative Expense
SCYNEXIS, Inc. (SCYX) reported Selling, General and Administrative Expense of $4.12 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-10
- SCYNEXIS, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $4.12M, a 8.85% increase year-over-year.
- SCYNEXIS, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $4.59M, a 23.13% increase year-over-year.
- SCYNEXIS, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $3.58M, a 24.09% decline year-over-year.
- SCYNEXIS, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $3.29M, a 13.07% increase year-over-year.
- SCYNEXIS, Inc. selling, general and administrative expense for fiscal 2025 was $14.39M, a 0.44% decline from fiscal 2024.
- SCYNEXIS, Inc. selling, general and administrative expense for fiscal 2024 was $14.46M, a 30.89% decline from fiscal 2023.
- SCYNEXIS, Inc. selling, general and administrative expense for fiscal 2023 was $20.92M, a 66.77% decline from fiscal 2022.
- SCYNEXIS, Inc. selling, general and administrative expense for fiscal 2022 was $62.96M, a 26.13% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.12M 10-Q · filed 2026-08-10 | $8.71M 10-Q · filed 2026-08-10 | $12.29M derived: sum of 3 quarters · filed 2026-08-10 | $15.57M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2026-03-31 | $4.59M 10-Q · filed 2026-05-11 | $8.17M derived: sum of 2 quarters · filed 2026-05-11 | $11.46M derived: sum of 3 quarters · filed 2026-05-11 | $15.24M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-12-31 | $3.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $6.87M derived: sum of 2 quarters · filed 2026-03-04 | $10.65M derived: sum of 3 quarters · filed 2026-08-10 | $14.39M 10-K · filed 2026-03-04 | |||
| 2025-09-30 | $3.29M 10-Q · filed 2025-11-05 | $7.07M derived: sum of 2 quarters · filed 2026-08-10 | $10.81M 10-Q · filed 2025-11-05 | $15.51M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-06-30 | $3.78M 10-Q · filed 2026-08-10 | $7.53M 10-Q · filed 2026-08-10 | $12.23M derived: sum of 3 quarters · filed 2026-08-10 | $15.13M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-03-31 | $3.73M 10-Q · filed 2026-05-11 | $8.44M derived: sum of 2 quarters · filed 2026-05-11 | $11.35M derived: sum of 3 quarters · filed 2026-05-11 | $14.52M derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | $4.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $7.62M derived: sum of 2 quarters · filed 2026-03-04 | $10.79M derived: sum of 3 quarters · filed 2026-03-04 | $14.46M 10-K · filed 2026-03-04 | |||
| 2024-09-30 | $2.91M 10-Q · filed 2025-11-05 | $6.07M derived: sum of 2 quarters · filed 2025-11-05 | $9.74M 10-Q · filed 2025-11-05 | $13.33M derived: sum of 4 quarters · filed 2025-11-05 | |||
| 2024-06-30 | $3.17M 10-Q · filed 2025-08-13 | $6.83M 10-Q · filed 2025-08-13 | $10.43M derived: sum of 3 quarters · filed 2025-08-13 | $15.44M derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | $3.67M 10-Q · filed 2025-05-15 | $7.26M derived: sum of 2 quarters · filed 2025-05-15 | $12.28M derived: sum of 3 quarters · filed 2025-05-15 | $19.75M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $3.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $8.61M derived: sum of 2 quarters · filed 2025-03-12 | $16.08M derived: sum of 3 quarters · filed 2025-03-12 | $20.92M 10-K · filed 2025-03-12 | |||
| 2023-09-30 | $5.01M 10-Q · filed 2024-11-06 | $12.49M derived: sum of 2 quarters · filed 2024-11-06 | $17.33M 10-Q · filed 2024-11-06 | $33.29M derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-06-30 | $7.47M 10-Q · filed 2024-08-08 | $12.31M 10-Q · filed 2024-08-08 | $28.27M derived: sum of 3 quarters · filed 2024-08-08 | $45.01M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | $4.84M 10-Q · filed 2024-05-08 | $20.80M derived: sum of 2 quarters · filed 2024-05-08 | $37.54M derived: sum of 3 quarters · filed 2024-05-08 | $53.33M derived: sum of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | $15.96M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $32.70M derived: sum of 2 quarters · filed 2024-03-28 | $48.48M derived: sum of 3 quarters · filed 2024-03-28 | $62.96M 10-K · filed 2024-03-28 | |||
| 2022-09-30 | $16.74M 10-Q · filed 2023-11-13 | $32.52M derived: sum of 2 quarters · filed 2023-11-13 | $47.00M 10-Q · filed 2023-11-13 | $62.15M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $15.79M 10-Q · filed 2023-08-14 | $30.26M 10-Q · filed 2023-08-14 | $45.41M derived: sum of 3 quarters · filed 2023-08-14 | $60.83M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $14.59M 10-Q · filed 2023-05-10 | $29.63M derived: sum of 2 quarters · filed 2023-05-10 | $45.04M derived: sum of 3 quarters · filed 2023-05-10 | $57.81M derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | $15.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $30.45M derived: sum of 2 quarters · filed 2023-03-31 | $43.22M derived: sum of 3 quarters · filed 2023-03-31 | $49.92M 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $15.41M 10-Q · filed 2022-11-09 | $28.18M derived: sum of 2 quarters · filed 2022-11-09 | $34.88M 10-Q · filed 2022-11-09 | $40.06M derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2021-06-30 | $12.77M 10-Q · filed 2022-08-15 | $19.47M 10-Q · filed 2022-08-15 | $24.65M derived: sum of 3 quarters · filed 2022-08-15 | $28.13M derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $6.70M 10-Q · filed 2022-05-12 | $11.88M derived: sum of 2 quarters · filed 2022-05-12 | $15.36M derived: sum of 3 quarters · filed 2022-05-12 | $18.71M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $5.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $8.66M derived: sum of 2 quarters · filed 2022-03-29 | $12.02M derived: sum of 3 quarters · filed 2022-03-29 | $14.63M 10-K · filed 2022-03-29 | |||
| 2020-09-30 | $3.48M 10-Q · filed 2021-11-10 | $6.84M derived: sum of 2 quarters · filed 2021-11-10 | $9.45M 10-Q · filed 2021-11-10 | $12.60M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $3.36M 10-Q · filed 2021-08-16 | $5.97M 10-Q · filed 2021-08-16 | $9.12M derived: sum of 3 quarters · filed 2021-08-16 | $11.60M derived: sum of 4 quarters · filed 2021-08-16 | |||
| 2020-03-31 | $2.61M 10-Q · filed 2021-05-17 | $5.76M derived: sum of 2 quarters · filed 2021-05-17 | $8.24M derived: sum of 3 quarters · filed 2021-05-17 | $11.02M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $5.63M derived: sum of 2 quarters · filed 2021-03-29 | $8.41M derived: sum of 3 quarters · filed 2021-03-29 | $10.65M 10-K · filed 2021-03-29 | |||
| 2019-09-30 | $2.48M 10-Q · filed 2020-11-06 | $5.26M derived: sum of 2 quarters · filed 2020-11-06 | $7.50M 10-Q · filed 2020-11-06 | $9.65M derived: sum of 4 quarters · filed 2020-11-06 | |||
| 2019-06-30 | $2.78M 10-Q · filed 2020-08-10 | $5.02M 10-Q · filed 2020-08-10 | $7.17M derived: sum of 3 quarters · filed 2020-08-10 | $9.61M derived: sum of 4 quarters · filed 2020-08-10 | |||
| 2019-03-31 | $2.24M 10-Q · filed 2020-05-11 | $4.39M derived: sum of 2 quarters · filed 2020-05-11 | $6.83M derived: sum of 3 quarters · filed 2020-05-11 | $8.95M derived: sum of 4 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $4.58M derived: sum of 2 quarters · filed 2020-03-11 | $6.71M derived: sum of 3 quarters · filed 2020-03-11 | $8.68M 10-K · filed 2020-03-11 | |||
| 2018-09-30 | $2.43M 10-Q · filed 2019-11-12 | $4.56M derived: sum of 2 quarters · filed 2019-11-12 | $6.53M 10-Q · filed 2019-11-12 | $8.35M derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | $2.12M 10-Q · filed 2019-08-07 | $4.09M 10-Q · filed 2019-08-07 | $5.92M derived: sum of 3 quarters · filed 2019-08-07 | $7.92M derived: sum of 4 quarters · filed 2019-08-07 | |||
| 2018-03-31 | $1.97M 10-Q · filed 2019-05-08 | $3.80M derived: sum of 2 quarters · filed 2019-05-08 | $5.80M derived: sum of 3 quarters · filed 2019-05-08 | $8.16M derived: sum of 4 quarters · filed 2019-05-08 | |||
| 2017-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $3.83M derived: sum of 2 quarters · filed 2019-03-14 | $6.19M derived: sum of 3 quarters · filed 2019-03-14 | $8.25M 10-K · filed 2019-03-14 | |||
| 2017-09-30 | $2.00M 10-Q · filed 2018-11-13 | $4.37M derived: sum of 2 quarters · filed 2018-11-13 | $6.42M 10-Q · filed 2018-11-13 | $8.34M derived: sum of 4 quarters · filed 2018-11-13 | |||
| 2017-06-30 | $2.36M 10-Q · filed 2018-08-09 | $4.42M 10-Q · filed 2018-08-09 | $6.33M derived: sum of 3 quarters · filed 2018-08-09 | $8.21M derived: sum of 4 quarters · filed 2018-08-09 | |||
| 2017-03-31 | $2.06M 10-Q · filed 2018-05-08 | $3.97M derived: sum of 2 quarters · filed 2018-05-08 | $5.85M derived: sum of 3 quarters · filed 2018-05-08 | $7.53M derived: sum of 4 quarters · filed 2018-05-08 | |||
| 2016-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $3.79M derived: sum of 2 quarters · filed 2018-03-13 | $5.46M derived: sum of 3 quarters · filed 2018-03-13 | $8.00M 10-K · filed 2018-03-13 | |||
| 2016-09-30 | $1.88M 10-Q · filed 2017-11-07 | $3.55M derived: sum of 2 quarters · filed 2017-11-07 | $6.09M 10-Q · filed 2017-11-07 | $8.62M derived: sum of 4 quarters · filed 2017-11-07 | |||
| 2016-06-30 | $1.67M 10-Q · filed 2017-08-08 | $4.21M 10-Q · filed 2017-08-08 | $6.74M derived: sum of 3 quarters · filed 2017-08-08 | $10.89M derived: sum of 4 quarters · filed 2017-08-08 | |||
| 2016-03-31 | $2.53M 10-Q · filed 2017-05-08 | $5.07M derived: sum of 2 quarters · filed 2017-05-08 | $9.21M derived: sum of 3 quarters · filed 2017-05-08 | $12.49M derived: sum of 4 quarters · filed 2017-05-08 | |||
| 2015-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $6.68M derived: sum of 2 quarters · filed 2017-03-13 | $9.96M derived: sum of 3 quarters · filed 2017-03-13 | $12.17M 10-K · filed 2017-03-13 | |||
| 2015-09-30 | $4.14M 10-Q · filed 2016-11-07 | $7.42M derived: sum of 2 quarters · filed 2016-11-07 | $9.63M 10-Q · filed 2016-11-07 | $11.66M derived: sum of 4 quarters · filed 2017-03-13 | |||
| 2015-06-30 | $3.27M 10-Q · filed 2016-08-08 | $5.49M 10-Q · filed 2016-08-08 | $7.52M derived: sum of 3 quarters · filed 2017-03-13 | $9.64M derived: sum of 4 quarters · filed 2017-03-13 | |||
| 2015-03-31 | $2.21M 10-Q · filed 2016-05-09 | $2.23M 10-Q · filed 2015-05-15 | $4.24M derived: sum of 2 quarters · filed 2017-03-13 | $6.37M derived: sum of 3 quarters · filed 2017-03-13 | $8.62M derived: sum of 4 quarters · filed 2017-03-13 | ||
| 2014-12-31 | $2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $4.16M derived: sum of 2 quarters · filed 2017-03-13 | $6.41M derived: sum of 3 quarters · filed 2017-03-13 | $7.62M 10-K · filed 2017-03-13 | $7.57M 10-K · filed 2015-03-30 | ||
| 2014-09-30 | $2.12M 10-Q · filed 2015-11-13 | $2.05M 10-Q · filed 2014-11-13 | $4.38M derived: sum of 2 quarters · filed 2015-11-13 | $5.58M 10-Q · filed 2015-11-13 | $5.51M 10-Q · filed 2014-11-13 | $6.81M derived: sum of 4 quarters · filed 2015-11-13 | |
| 2014-06-30 | $2.25M 10-Q · filed 2015-08-19 | $3.46M 10-Q · filed 2015-08-19 | $4.69M derived: sum of 3 quarters · filed 2015-10-30 | $5.83M derived: sum of 4 quarters · filed 2015-10-30 | |||
| 2014-03-31 | $1.21M 8-K · filed 2015-10-30 | $2.44M derived: sum of 2 quarters · filed 2015-10-30 | $3.58M derived: sum of 3 quarters · filed 2015-10-30 | $4.50M derived: sum of 4 quarters · filed 2015-10-30 | |||
| 2013-12-31 | $1.23M derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30 | $2.37M derived: sum of 2 quarters · filed 2015-10-30 | $3.29M derived: sum of 3 quarters · filed 2015-10-30 | $4.38M 8-K · filed 2015-10-30 | |||
| 2013-09-30 | $1.14M 10-Q · filed 2014-11-13 | $2.06M derived: sum of 2 quarters · filed 2014-11-13 | $3.15M 10-Q · filed 2014-11-13 | ||||
| 2013-06-30 | $918.00K 10-Q · filed 2014-08-13 | $2.01M 10-Q · filed 2014-08-13 | |||||
| 2013-03-31 | $1.09M 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |